GL1X · GenesisL1 explorer

Research workbench

Crystal structure of GSK3BETA in complex with a imidazopyridine inhibitor

Analyse Crystal structure of GSK3BETA in complex with a imidazopyridine inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4DIT
Type
protein
Length
329 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycogen synthase kinase-3 beta
EC
2.7.11.26, 2.7.11.1
UniProt
P49841
Ligands
0KD
Pockets
3 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycogen synthase kinase-3 beta (EC 2.7.11.26, 2.7.11.1)protein32935% helix, 18% strandP49841

Ligands and binding sites

  • 0KD · N-(pyridin-3-yl)-2-(thiophen-3-yl)-3H-imidazo[4,5-b]pyridine-7-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15290.690.79600KD
2780.410.7919empty
3660.330.7619empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 4DIT · Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.